Your search returned 24 studies. (Get alerts for new studies):
- PF-00299804 As A Single Oral Agent In Selected Patients With Adenocarcinoma Of The Lung
Conditions: Carcinoma, Non-small Cell
6 Locations available
- A Phase I Study of Belinostat in Combination With Cisplatin and Etoposide in Adults With Small Cell Lung Carcinoma and Other Advanced Cancers
Conditions: Small Cell Lung Carcinoma - Malignant Epithelial Neoplasms
1 Location available
- An Investigational Drug, PF-02341066, Is Being Studied In Patients With Advanced Non-Small Cell Lung Cancer With A Specific Gene Profile Involving The
Conditions: Carcinoma, Non-Small-Cell Lung
13 Locations available
- Phase 3 Study of Tavocept Versus Placebo in Patients With Newly Diagnosed or Relapsed Advanced Primary Adenocarcinoma of the Lung Treated With Docetax
Conditions: Non-small Cell Lung Cancer
4 Locations available
- A Study of Erlotinib Plus Radiotherapy (RT) for Patients With Advanced or Inoperable Non-Small-Cell Lung Cancer
Conditions: Carcinoma, Non-small-cell Lung
2 Locations available
- A Study of MM-121 Combination Therapy in Patients With Advanced Non-Small Cell Lung Cancer
Conditions: Carcinoma, Non-Small-Cell Lung
5 Locations available
- A Study of Cisplatin + Pemetrexed + Avastin as First-Line Therapy in Patients With Advanced Non-Small Cell Lung Carcinoma (NSCLC)
Conditions: Non-Small Cell Lung Cancer
2 Locations available
- A Study in Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck
Conditions: Ovarian Cancer - Non Small Cell Lung Cancer - Prostate Cancer - Colorectal Cancer - Gastric Cancer - Esophageal Cancer - Cancer of Head and Neck
23 Locations available
- Study of PX-866 and Docetaxel in Solid Tumors
Conditions: Non Small Cell Lung Cancer (NSCLC) - Squamous Cell Carcinoma of the Head and Neck (SCCHN)
28 Locations available
- Residual Hypermethylation in Early Stage Non-Small Cell Lung Cancer (NSCLC) As Part of Adjuvant Therapy and Preventive Strategy
Conditions: Lung Cancer - Non Small Cell Lung Carcinoma - Hypermethylation
1 Location available
- Hsp90 Inhibitor AUY922 and Erlotinib Hydrochloride in Treating Patients With Stage IIIB-IV Non-Small Cell Lung Cancer
Conditions: Adenocarcinoma of the Lung - Non-small Cell Lung Cancer
1 Location available
- An Efficacy and Safety Study to Assess [18F]-ML-10 in Detecting Response of Tumors to Chemotherapy and Radiation
Conditions: Carcinoma, Non-Small-Cell Lung - Head and Neck Neoplasms
4 Locations available
- Study of ACE-011 to Determine Safe and Effective Dose of ACE-011 for the Treatment of Chemotherapy Induced Anemia in Patients With Advanced Non-small
Conditions: Anemia - Carcinoma, Non-Small-Cell Lung - Carcinoma, Small-Cell Lung - Bladder Cancer - Cancer of Head and Neck - Uterine Cervical Cancer
39 Locations available
- Molecular Profiling and Targeted Therapy for Advanced Non-Small Cell Lung Cancer, Small Cell Lung Cancer, and Thymic Malignancies
Conditions: Carcinoma, Non-Small-Cell Lung - Carcinoma, Small Cell Lung - Carcinoma, Thymic
2 Locations available
- Image-Guided Hypofractionated Radiation Therapy With Stereotactic Body Radiation Therapy Boost and Combination Chemotherapy in Treating Patients With
Conditions: Adenocarcinoma of the Lung - Adenosquamous Cell Lung Cancer - Large Cell Lung Cancer - Recurrent Non-small Cell Lung Cancer - Squamous Cell Lung Cancer - Stage IIA Non-small Cell Lung Cancer - Stage IIB Non-small Cell Lung Cancer - Stage IIIA Non-small Ce
1 Location available
- A Phase 2, Open-Label Study of Amuvatinib in Combination With Platinum-Etoposide Chemotherapy in Small Cell Lung Cancer
Conditions: Small Cell Lung Carcinoma
7 Locations available
- Biodistribution and Safety of the PET Probes [18F]FPRGD2 and [18F]FPPRGD2
Conditions: Breast Cancer - Lung Cancer - Carcinoma, Non-Small-Cell Lung - Cancer of Brain and Nervous System - Glioblastoma
1 Location available
- Molecular Analysis of Thoracic Malignancies
Conditions: Thymus Cancer - Thymoma - Thymic Carcinoma - Lung Cancer - Carcinoma, Non-Small-Cell Lung - Mesothelioma
1 Location available
- Depsipeptide/Flavopiridol Infusion for Cancers of the Lungs, Esophagus, Pleura, Thymus or Mediastinum
Conditions: Carcinoma, Small Cell - Carcinoma, Non-small-cell Lung - Esophageal Neoplasms - Mesothelioma
1 Location available
- A Phase 1/2 Study of the Oral ALK/EGFR Inhibitor AP26113
Conditions: Advanced Malignancies - Carcinoma, Non-Small-Cell Lung - Anaplastic Large Cell Lymphoma - Diffuse Large Cell Lymphoma - Inflammatory Myofibroblastic Tumors
6 Locations available
- Talactoferrin in Treating Patients With Relapsed or Refractory Non-Small Cell Lung Cancer or Squamous Cell Head and Neck Cancer
Conditions: Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma - Recurrent Metastatic Squamous Neck Cancer With Occult Primary - Recurrent Salivary Gland Cancer - Recurrent Squamous Cell Carcinoma of the Hypopharynx - Recurrent Squamous Cell
1 Location available
- Neuroprotective Effects of Lithium in Patients With Small Cell Lung Cancer Undergoing Radiation Therapy to the Brain
Conditions: Small Cell Lung Carcinoma
1 Location available
- Study Assessing Safety, Pharmacokinetics and Efficacy of CC-223 With Either Erlotinib or Oral Azacitidine in Advanced Non-Small Cell Lung Cancer
Conditions: Carcinoma, Non-Small-Cell Lung - Non-Small Cell Lung Cancer
1 Location available
- A Randomized Phase II Study of Metformin Plus Paclitaxel/Carboplatin/Bevacizumab in Patients With Adenocarcinoma.
Conditions: Patients Must Have Histologically or Cytologically Confirmed Non-squamous Cell, Non Small Cell Carcinoma of the Lung. - Patient Must Have Measurable Stage IV Disease (Includes M1a, M1b Stages or Recurrent Disease).
1 Location available
|